Full Year 2022 Dr Martens PLC Earnings Call Transcript
Okay. Good morning, everyone, and thank you for joining us today both in person. It's great to have an in-person audience again and on the webcast. I'm Kenny Wilson, the CEO of Dr. Martens, and I'll be joined today by Jon Mortimore, our Chief Financial Officer. Also, in the audience, we have Paul Mason, our Chairman; and Emily Reichwald, our Chief Legal Counsel.
Iâm sure that most of you know Bethany, our IR Director. Well, Bethany is off on maternity leave in just a few weeks. So I'm also pleased to welcome Mark Blythman today as our interim Head of Investor Relations. And if you've got any questions in the weeks ahead, then please reach out to Mark.
So our agenda for today, well, I'm going to talk us through the key takeaways for our financial year '22, and then Jon is going to pick up and take us through a detailed review of our financial performance. And then I'll come back to talk about our strategic performance, but probably more importantly, why I feel really confident about financial year '23, the year ahead and even more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |